Home > Healthcare > Medical Devices > Therapeutic Devices > Dialyzers Market

Dialyzers Market Trends

Report ID: GMI4684
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Dialyzers Market Trends

Technological advancements have led to the development of high-efficiency hemodialysis equipment and hemodiafiltration systems. These innovations enable more effective removal of waste products and toxins from the blood during dialysis, enhancing the overall therapeutic outcomes for patients.

Ongoing research and development efforts have resulted in innovative dialyzer designs with improved biocompatibility and enhanced dialysis performance. Novel materials and membrane technologies contribute to reducing the risk of complications and increasing the efficiency of the dialysis process.
For instance, in May 2020, Outset Medical a U.S.-based medical technology company launched the Tablo hemodialysis system. This system aims to simplify and improve patient convenience with advanced dialysis features. Tablo hemodialysis system is suitable for providing extended therapy for 24 hours (XT), slow low-efficiency dialysis (SLED), standard hemodialysis (HD), isolated ultrafiltration (UF only), and sequential therapy, that is HD-UF and UF-HD.
Moreover, the introduction of online hemodiafiltration systems represents a significant technological leap in dialysis. OL-HDF combines hemodialysis and hemodiafiltration, offering improved clearance of larger molecular weight toxins and providing superior clinical outcomes for patients undergoing dialysis, contributing to market development.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Dialyzers industry was worth USD 5.2 billion in revenue in 2023 and is anticipated to expand at 7% CAGR from 2024-2032 driven by the increasing prevalence of chronic kidney diseases coupled with the rising demand for home dialysis therapies.

High-flux segment generated more than USD 3.5 billion in 2023 and is estimated to witness high demand through 2032 owing to its design to help achieve superior solute removal efficiency during the dialysis process.

North America dialyzers industry size was worth USD 2.2 billion in 2023 and is set to expand at a robust pace through 2032 attributed to the high prevalence of kidney-related disorders, especially in older people.

Some of the top dialyzer firms are Allmed Medical Care Holdings Limited, Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Baxter International Inc., China Chengdu Wesley Biotech Co., Dialifegroup, Farmasol, Fresenius SE & Co. KGaA, Kawasumi Laboratories Inc., Medica Group, Medivators, Inc., Medtronic, Plc., and Nikkiso Co., Ltd.